Thermo Fisher Scientific Income Statement Analysis

Revenue, earnings, and profit margins in billions USD

Scroll to see more
Thermo Fisher Scientific Inc. income statement - Annual data in billions USD
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period EndingDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
Revenue & Gross Profit
Revenue44.5642.8842.8644.9239.2132.2225.5424.36
Cost of Revenue25.9825.1325.7625.9419.5716.2110.0413.50
Gross Profit18.5717.7517.1018.9719.6416.0015.5110.86
Operating Expenses
Research & Development1.401.391.341.471.411.181.000.97
Selling, General & Administrative7.078.608.458.948.016.946.146.06
Operating Expenses10.2010.029.7810.419.418.147.157.02
Operating Income8.377.736.868.5610.037.874.593.83
Other Income/Expense
Interest Income0.991.080.880.270.040.070.000.14
Interest Expense-1.42-1.391.38-0.73-0.54-0.550.000.67
Other Income/Expense0.000.01-0.52-0.040.700.010.07-0.04
Income
Income Before Tax7.277.006.307.668.847.234.073.26
Income Tax Expense0.550.660.280.701.110.850.370.32
Net Income6.706.346.006.957.736.383.702.94
Net Income - Continuous Operations6.746.345.966.967.730.000.000.00
Net Income - Discontinued Operations0.000.000.000.000.000.000.000.00
EBITDA11.1510.8411.0811.9411.9710.196.236.20
EBIT8.377.737.678.569.387.873.963.93
Depreciation & Amortization2.783.111.073.380.832.330.561.74
Earnings Per Share
Basic EPS18.0017.0016.0018.0020.0016.0018.007.00
Diluted EPS18.0017.0015.0018.0019.0016.0018.007.00
Basic Shares Outstanding0.380.380.390.390.390.400.400.40
Diluted Shares Outstanding0.380.380.390.390.400.400.400.41